Keeping the flame alive…

Today, once again, Novogen announced that it has filed a couple of patents. Not received a notice of allowance or won an opposition or anything of commercial significance, but you know, just paperwork. Well done to Andrew Heaton and the team for getting some cunning new technology put down on the pageĀ – and especially a…

Prima Files a Patent

Prima has had an amazing couple of couple of weeks. A stratospheric stock adjustment that seems to have stuck (nice!). Some good visibility, no doubt, around ASCO time which is great. There remains an odd, slightly contrived echo of jubilation that CVac is an exciting outcome (I’ve already addressed thisĀ so I am not going to…

NRT, ANP, PYC, ACL, OBJ : A Week in Contrast

Last week was a pretty exciting week in Australian life sciences. Quite a bit happened, in fact I struggled to stay on top of it while being on vacation. We’ve seen a couple of good things happen, like PharmAxis, Sirtex recovery, etc. that are real bright spots on the Aussie biotech landscape. We’ve seen some…

Cock-a-doodle-doo…

I’m abroad at the moment and I have been getting up very early each day to try and catch up on the morning news back in Australia. Fortunately, a lot of people have also been helping me to stay on top of news flow while I am away and several people forwarded me Tony Boyd’s…

Nothing “Novo” about Novogen

I’ll keep this brief, because there isn’t much to say. My ire with this company blossomed last month when it announced that it had filed a patent. Yes, you heard me correctly. They didn’t receive a notice of allowance on a patent. They didn’t expand their intellectual property (IP) into an international territory of commercial…